Fig. 1
From: Nanotechnology approaches to addressing HER2-positive breast cancer
Comparison of the number of breast cancer and nanoparticle (BC and NP in blue) and HER2-positive breast cancer and nanoparticle (HER2+ BC and NP in orange) related publications by year from 2009 to 2020. The data were taken from PubMed (https://pubmed.ncbi.nlm.nih.gov/) on August 20, 2020 and is based on a keyword search using the keywords: “Breast cancer and nanoparticles”, and “HER2-positive breast cancer and nanoparticles”. PubMed was also searched for a comprehensive review of the literature for nanotechnology uses in HER2-positive breast cancer